Literature DB >> 3336795

Nipple discharge: surgical significance.

H P Leis1, F L Greene, A Cammarata, S E Hilfer.   

Abstract

Nipple discharge is an important clinical entity ranking second only to a lump as the most common complaint among 7,588 patients having breast surgery (560/7,588, or 7.4%). In the office and clinic it is even more common, since many patients can be treated medically and do not require an operation. To be significant, a discharge should be true, spontaneous, persistent, and nonlactational. Nipple discharge can be milky, multicolored and sticky, purulent, clear (watery), yellow (serous), pink (serosanguineous), or bloody (sanguineous). Watery, serous, serosanguineous, and sanguineous discharges are surgically significant; while they are most often caused by intraductal papillomas or fibrocystic disease, they can be due to cancer or a precancerous mastopathy. Among 503 patients operated on for one of these types of discharge, 67 (13.3%) had cancer, and 36 (7.2%) had a precancerous mastopathy. Among the 67 patients with cancer, eight (11.9%) had no palpable mass, 11 (16.4%) had negative cytologic findings, and seven (10.4%) had a negative mammogram. The incidence of associated cancers increases when the discharge is, in order of increasing frequency, serous, serosanguineous, sanguineous, or watery, when it is accompanied by a lump, when it is unilateral and from a single duct, when there are positive cytologic or mammographic findings, and when the patient is more than 50 years of age. Milky discharge caused by galactorrhea is treated medically except when caused by a pituitary adenoma. Multicolored sticky discharge due to duct ectasia is also treated medically except in advanced cases. Purulent discharge caused by an abscess requires drainage and a biopsy of the abscess wall. Except in women less than 30 years of age of in those anxious to have children, we advise a complete central duct excision for patients with surgically significant types of discharge. If done carefully, this procedure can yield good cosmetic results.

Entities:  

Mesh:

Year:  1988        PMID: 3336795     DOI: 10.1097/00007611-198801000-00005

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Can galactography-guided stereotactic, 11-gauge, vacuum-assisted breast biopsy of intraductal lesions serve as an alternative to surgical biopsy?

Authors:  Caecilia S Reiner; Thomas H Helbich; Margaretha Rudas; Lothar Ponhold; Christopher C Riedl; Nina Kropf; Michael H Fuchsjäger
Journal:  Eur Radiol       Date:  2009-12       Impact factor: 5.315

Review 2.  Cystic breast masses and the ACRIN 6666 experience.

Authors:  Wendie A Berg; Alan G Sechtin; Helga Marques; Zheng Zhang
Journal:  Radiol Clin North Am       Date:  2010-09       Impact factor: 2.303

3.  The INTEND 1 randomized controlled trial of duct endoscopy as an indicator of margin excision in breast conservation surgery.

Authors:  Gerald Gui; Effrosyni Panopoulou; Sarah Tang; Dominique Twelves; Mohammed Kabir; Ann Ward; Catherine Montgomery; Ashutosh Nerurkar; Peter Osin; Clare M Isacke
Journal:  Breast Cancer Res Treat       Date:  2021-01-04       Impact factor: 4.872

4.  Galactography in patients with nipple discharge.

Authors:  J P Lamont; R P Dultz; J A Kuhn; M D Grant; R C Jones
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-07

Review 5.  Management of nipple discharge.

Authors:  H P Leis
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

6.  Reliability of Breast Ultrasound BI-RADS Final Assessment in Mammographically Negative Patients with Nipple Discharge and Radiologic Predictors of Malignancy.

Authors:  Chae Jung Park; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Min Jung Kim
Journal:  J Breast Cancer       Date:  2016-09-23       Impact factor: 3.588

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.